These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23422659)

  • 21. Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.
    Baranovich T; Bahl J; Marathe BM; Culhane M; Stigger-Rosser E; Darnell D; Kaplan BS; Lowe JF; Webby RJ; Govorkova EA
    Antiviral Res; 2015 May; 117():10-9. PubMed ID: 25701593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus.
    Woods CJ; Malaisree M; Pattarapongdilok N; Sompornpisut P; Hannongbua S; Mulholland AJ
    Biochemistry; 2012 May; 51(21):4364-75. PubMed ID: 22574858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1.
    Neri-Bazán RM; García-Machorro J; Méndez-Luna D; Tolentino-López LE; Martínez-Ramos F; Padilla-Martínez II; Aguilar-Faisal L; Soriano-Ursúa MA; Trujillo-Ferrara JG; Fragoso-Vázquez MJ; Barrón BL; Correa-Basurto J
    Eur J Med Chem; 2017 Mar; 128():154-167. PubMed ID: 28182988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comment on "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)".
    Rungrotmongkol T; Malaisree M; Udommaneethanakit T; Hannongbua S
    Biophys Chem; 2009 Apr; 141(1):131-2; author reply 133. PubMed ID: 19231807
    [No Abstract]   [Full Text] [Related]  

  • 25. [Function of neuraminidase of influenza virus and anti influenza compounds by its inhibition].
    Yamashita M
    Tanpakushitsu Kakusan Koso; 2009 Aug; 54(10):1284-91. PubMed ID: 19663256
    [No Abstract]   [Full Text] [Related]  

  • 26. Design, synthesis and biological evaluation of oseltamivir derivatives containing pyridyl group as potent inhibitors of neuraminidase for influenza A.
    Wang K; Lei Z; Zhao L; Chen B; Yang F; Liu K; Zhu H; Zhao H; Cao R; Zhang K; Tian Y
    Eur J Med Chem; 2020 Jan; 185():111841. PubMed ID: 31708183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A surface plasmon resonance assay for measurement of neuraminidase inhibition, sensitivity of wild-type influenza neuraminidase and its H274Y mutant to the antiviral drugs zanamivir and oseltamivir.
    Somasundaram B; Fee CJ; Fredericks R; Watson AJ; Fairbanks AJ; Hall RJ
    J Mol Recognit; 2015 Sep; 28(9):521-7. PubMed ID: 25727669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors.
    Tamura D; Sugaya N; Ozawa M; Takano R; Ichikawa M; Yamazaki M; Kawakami C; Shimizu H; Uehara R; Kiso M; Kawakami E; Mitamura K; Kawaoka Y
    Clin Infect Dis; 2011 Feb; 52(4):432-7. PubMed ID: 21248368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of human H1N1 influenza virus variants selected in vitro with zanamivir in the presence of sialic acid-containing molecules.
    Giannecchini S; Campitelli L; Bandini G; Donatelli I; Azzi A
    Virus Res; 2007 Nov; 129(2):241-5. PubMed ID: 17765996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neuraminidase inhibitors resistance in influenza viruses and the related mechanisms].
    Huang L; Zhou JF; Wei H; Shu YL
    Bing Du Xue Bao; 2012 Sep; 28(5):572-6. PubMed ID: 23233936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral activity of ethanol extract of Geranii Herba and its components against influenza viruses via neuraminidase inhibition.
    Choi JG; Kim YS; Kim JH; Chung HS
    Sci Rep; 2019 Aug; 9(1):12132. PubMed ID: 31431635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuraminidase inhibitors as anti-influenza virus agents.
    Kim CU; Chen X; Mendel DB
    Antivir Chem Chemother; 1999 Jul; 10(4):141-54. PubMed ID: 10480735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro evaluation of synergistic inhibitory effects of neuraminidase inhibitors and methylglyoxal against influenza virus infection.
    Charyasriwong S; Watanabe K; Rahmasari R; Matsunaga A; Haruyama T; Kobayashi N
    Arch Med Res; 2015 Jan; 46(1):8-16. PubMed ID: 25523147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008.
    Bauer K; Dürrwald R; Schlegel M; Pfarr K; Topf D; Wiesener N; Dahse HM; Wutzler P; Schmidtke M
    Med Microbiol Immunol; 2012 Feb; 201(1):61-72. PubMed ID: 21688167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season.
    Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
    J Infect Chemother; 2015 Jan; 21(1):39-42. PubMed ID: 25277670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.
    Gubareva LV; Webster RG; Hayden FG
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3403-8. PubMed ID: 11709315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substitutions at H134 and in the 430-loop region in influenza B neuraminidases can confer reduced susceptibility to multiple neuraminidase inhibitors.
    Mohr PG; Williams J; Tashiro M; Streltsov VA; McKimm-Breschkin JL
    Antiviral Res; 2020 Oct; 182():104895. PubMed ID: 32750469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.
    Burnham AJ; Armstrong J; Lowen AC; Webster RG; Govorkova EA
    J Virol; 2015 Apr; 89(8):4575-87. PubMed ID: 25673705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.
    Stoner TD; Krauss S; DuBois RM; Negovetich NJ; Stallknecht DE; Senne DA; Gramer MR; Swafford S; DeLiberto T; Govorkova EA; Webster RG
    J Virol; 2010 Oct; 84(19):9800-9. PubMed ID: 20660186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza viruses.
    Ilyushina NA; Govorkova EA; Gray TE; Bovin NV; Webster RG
    PLoS Pathog; 2008 Apr; 4(4):e1000043. PubMed ID: 18404209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.